Dental caries prevalence · Children with cerebral palsy in Dubai
Dental caries prevalence was 53% among children with cerebral palsy.
1 finding from 1 review
Prevalence 53
1 study
GRADE not reported
Calculus · Children with cerebral palsy in Dubai
The calculus index was 0.56 in children with cerebral palsy versus 0.07 in controls.
1 finding from 1 review
MEAN 0.56
1 study
GRADE not reported
Dental caries · Children with cerebral palsy in Dubai
Mean DMFT was 2.83 among children with cerebral palsy.
1 finding from 1 review
MEAN 2.83
1 study
GRADE not reported
Gingivitis · Children with cerebral palsy in Dubai
Gingivitis prevalence was 58.8% among children with cerebral palsy.
1 finding from 1 review
Prevalence 58.8
1 study
GRADE not reported
Oral health status (caries, gingivitis, calculus, treatment indices) · Children with cerebral palsy in Dubai
One study found children with cerebral palsy had caries and gingivitis similar to matched controls but more calculus and anomalies, with lower restorative care despite greater need (narrative synthesis; not GRADE-rated).
1 finding from 1 review
Al Hashmi et al. (Dubai) reported caries in 53% of children with cerebral palsy (mean DMFT 2.83) and gingivitis in 58.8%, similar to matched controls, but a significantly higher calculus index (0.56 vs 0.07) and more…
1 study
GRADE not reported
Death or cerebral palsy · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death or cerebral palsy (up to school age)** compared with placebo (outcomes (low certainty).
2 findings from 1 review
Cerebral palsy · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate leads to lower cerebral palsy (up to 2 years' corrected age)** compared with placebo (outcomes (high certainty).
2 findings from 1 review
Cerebral palsy · preterm or very low birth weight infants
It is very uncertain whether summary of findings table ‐ Silicone earplugs changes cerebral palsy at 18 to 22 months' corrected age compared with no earplugs (very low certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Individual tailored showed no clear difference in death or cerebral palsy at 1 to 3 years compared with continuous tapered dexamethasone regimen (moderate certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Lower showed no clear difference in death or cerebral palsy at 1 to 3 years compared with higher cumulative dose dexamethasone regimen (low certainty).
1 finding from 1 review
Death or cerebral palsy at 1 to 3 years · preterm infants at risk for bronchopulmonary dysplasia
Later showed no clear difference in death or cerebral palsy at 1 to 3 years compared with earlier initiation of dexamethasone therapy (low certainty).
1 finding from 1 review
Major neurological disability at 2 years of age (Defined as any of the following: legal blindness, sensorineural deafness requiring hearing aids, moderate or severe cerebral palsy or developmental delay/intellectual impairment (developmental quoti... · newborn infants at risk of neonatal hypoglycaemia
Dextrose gel showed no clear difference in major neurological disability at 2 years of age (Defined as any of… compared with placebo (low certainty).
1 finding from 1 review
a) Cerebral palsy or gross motor disability · preterm infants at risk for apnea
Methylxanthine showed no clear difference in a) Cerebral palsy or gross motor disability compared with placebo or control (moderate certainty).
1 finding from 1 review
a) Cerebral palsy or gross motor disability · preterm infants with apnea
Methylxanthine showed no clear difference in a) Cerebral palsy or gross motor disability compared with placebo or control (moderate certainty).
1 finding from 1 review
a) Cerebral palsy or gross motor disability · preterm infants prior to extubation
Methylxanthine probably leads to lower a) Cerebral palsy or gross motor disability compared with placebo or control (moderate certainty).
1 finding from 1 review
a) Cerebral palsy or gross motor disability · preterm infants at risk of or with apnea; preterm infants undergoing extubation
Methylxanthine probably leads to lower a) Cerebral palsy or gross motor disability compared with placebo or control (moderate certainty).
1 finding from 1 review
Cerebral palsy · very preterm or very low birth weight infants
1 finding from 1 review
Cerebral palsy · preterm infants
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cerebral palsy · women at risk of preterm birth
Dexamethasone showed no clear difference in cerebral palsy compared with betamethasone – child outcomes (low certainty).
1 finding from 1 review
Major neurological disability at 2 years of age (Defined as any of the following: legal blindness, sensorineural deafness requiring hearing aids, moderate or severe cerebral palsy or developmental delay/intellectual impairment (developmental quoti... · newborn infants with hypoglycaemia
Oral dextrose gel showed no clear difference in major neurological disability at age 2 years or olderb Defined as… compared with control (low certainty).
1 finding from 1 review